SusanFayeDentMD

Oncology • Rochester, NY

Physician

Join to view full profile

Dr. Dent is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dent's full profile

Already have an account?

Office
601 Elmwood Ave
# 704
Rochester, NY 14642
Phone+1 919-613-4077

Fax+1 919-613-4077

Education & Training

Michael G. DeGroote School of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 2024 - 2026
NC State Medical License 2018 - 2024

Clinical Trials

Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) Start of enrollment: 2020 Nov 13
Terminated
Phase 1
STOP-HER2: Stopping Trastuzumab in HER2+ MBC Start of enrollment: 2023 Apr 19
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Cardiovascular Health in Breast Cancer: Survivorship Care.
Coralea Kappel, Robin Tumlinson, Susan Dent
Cardiology Clinics. 2025-02-01
1 citations
Breast cancer and cardiovascular health.
Teresa López-Fernández, Irene Marco, Marianne C Aznar, Ana Barac, Jutta Bergler-Klein
European Heart Journal. 2024-11-07
2 citations
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncol...
Carlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, Maria Sol Andres, Liam S Couch
European Journal of Heart Failure. 2024-10-01

Authored Content

Highlights from SABCS 2024December 2024
Cardio-Oncology Is a Growing Subspecialty, but Where Are the OncologistsFebruary 2024
Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast CancerDecember 2022

Press Mentions

Atrium Health Receives Grant to Help Researchers Uncover Signs of Heart Damage in Breast Cancer SurvivorsJuly 7th, 2022
Professor Receives Grant to Develop Breast Cancer Therapy That Combats Drug ResistanceSeptember 20th, 2021
PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing ChemotherapyJune 23rd, 2021
Join now to see all